v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities:          
Net Income $ 165,239 $ 202,103 $ 716,329 $ 436,910  
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:          
Depreciation, Depletion and Amortization 134,645 149,323 405,490 428,979  
Amortization of Deferred Financing Costs     6,788 8,083  
Stock-Based Compensation     18,796 19,065  
Gain on Asset Sales and Abandonments, net     (9,255) (94,759)  
Loss on Debt Extinguishment 0 0 12,009 0  
Gain on Commodity Derivative Instruments (160,563) (131,695) (340,880) (24,596)  
Net Cash Paid in Settlement of Commodity Derivative Instruments     (208,527) (161,977)  
Deferred Income Taxes     160,423 140,140  
Other     1,334 1,842  
Changes in Operating Assets:          
Accounts and Notes Receivable     130,336 49,036  
Supplies Inventories     (7,795) (16,250)  
Prepaid Expenses     (1,240) (1,575)  
Changes in Other Assets     14,536 22,883  
Changes in Operating Liabilities:          
Accounts Payable     (27,844) (17,974)  
Accrued Interest     (27,053) (15,393)  
Other Operating Liabilities     (15,094) (20,388)  
Changes in Other Liabilities     (17,795) (22,118)  
Net Cash Provided by Operating Activities     810,558 731,908  
Cash Flows from Investing Activities:          
Capital Expenditures     (451,058) (320,574)  
Proceeds from Asset Sales     48,723 105,207  
Investment in Equity Affiliates     (5,615) (3,303)  
Apex Acquisition (Net of Cash Acquired)     (10,255) (517,599)  
Net Cash Used in Investing Activities     (418,205) (736,269)  
Cash Flows from Financing Activities:          
Payments on Long-Term Notes     (507,965) 0  
Payments on Other Debt     (3,914) (3,089)  
Proceeds from Issuance of Common Stock     3,385 986  
Shares Withheld for Taxes     (17,249) (13,840)  
Purchases of Common Stock     (434,678) (423,226)  
Debt Issuance and Financing Fees     (8,090) (960)  
Net Cash Used in Financing Activities     (401,411) (33,379)  
Net Decrease in Cash, Cash Equivalents and Restricted Cash     (9,058) (37,740)  
Cash, Cash Equivalents and Restricted Cash at Beginning of Period     13,464 55,073 $ 55,073
Cash, Cash Equivalents and Restricted Cash at End of Period $ 4,406 $ 17,333 4,406 17,333 $ 13,464
CNXM Revolving Credit Facility          
Cash Flows from Financing Activities:          
Net Proceeds from Revolving Credit Facility     273,050 252,925  
Net Payments on Revolving Credit Facility     (238,800) (248,475)  
CNX Revolving Credit Facility          
Cash Flows from Financing Activities:          
Net Proceeds from Revolving Credit Facility     1,549,700 1,574,600  
Net Payments on Revolving Credit Facility     (1,516,850) (1,370,800)  
CNX Senior Notes          
Cash Flows from Financing Activities:          
Proceeds from Issuance of CNX Senior Notes     $ 500,000 $ 198,500